Keyphrases
MTOR Inhibitor
100%
Tuberous Sclerosis Complex
100%
Astrocytic Hamartoma
100%
Tumor
71%
Tumor Size
57%
Retinal Astrocytic Hamartoma
42%
Ocular Manifestations
28%
Medical Records
14%
Treatment Outcome
14%
Medical Center
14%
Consecutive Patients
14%
Heidelberg
14%
SHEBA
14%
Medical History
14%
Pathogenic Mechanism
14%
Young Patients
14%
Spectral Domain Optical Coherence Tomography (SD-OCT)
14%
Follow-up Interval
14%
Neurologic
14%
Lesion Measurement
14%
Tuberous Sclerosis
14%
Fundus Image
14%
Optic Disc
14%
Five Eyes
14%
Ocular Involvement
14%
ImageJ Software
14%
Ocular Presentations
14%
Ocular Treatment
14%
Neurocutaneous Disorders
14%
Spectralis
14%
Basis Reduction
14%
Medicine and Dentistry
Neoplasm
100%
Hamartoma
100%
Mammalian Target of Rapamycin Inhibitor
100%
Tuberous Sclerosis
100%
Optical Coherence Tomography
22%
Base
11%
Medical Record
11%
Medical History
11%
Optic Disc
11%
Dermatological Agent
11%
Phakomatosis
11%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Mammalian Target of Rapamycin Inhibitor
100%
Hamartoma
100%
Tuberous Sclerosis
100%
Base
11%
Medical History
11%
Dermatological Agent
11%
Phakomatosis
11%